Molecular aspects of organic compound transport across the plasma membrane of hepatocytes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 5, 1999, Pages 405-412

  Kamisako, Toshinori ^a   Gabazza, Esteban C ^b   Ishihara, Tomoaki ^b   Adachi, Yukihiko ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP binding cassette transporters; Bile acids; Bilirubin; Hepatic excretion; Hepatic uptake

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; ORGANIC COMPOUND;

BILE ACID METABOLISM; BILIARY EXCRETION; CELL MEMBRANE TRANSPORT; HUMAN; INTRAHEPATIC BILE DUCT; LIVER CELL MEMBRANE; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSPORT KINETICS;

EID: 0032986770     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01886.x     Document Type: Review

References (75)

1. 1 Inoue M, Kinne R, Tran T, Arias IM. Taurocholate transport by rat liver sinusoidal membrane vesicles: Evidence of sodium cotransport. Hepatology 1982; 2: 572-9.
2. 2 Von Dippe P, Ananthanarayanan M, Drain P, Levy D. Purification and reconstitution of the bile acid transport system from hepatocyte sinusoidal plasma membrane. Biochim. Biophys. Acta 1986; 862: 352-60.
3. 3 Von Dippe P, Levy D. Reconstitution of the immunopurified 49 kDa sodium-dependent bile acid transporter protein derived from hepatocyte sinusoidal membrane. J. Biol. Chem. 1990; 265: G14812-16.
4. 4 Ananthanarayanan M, Ng OC, Boyer JL, Suchy FJ. Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies. Am. J. Physiol. 1994; 267: G637-43.
5. 5 Meier PJ. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am. J. Physiol. 1995; 269: G801-12.
6. 6 Green RM, Gollan RM, Hagenbuch B, Meier PJ, Beier D. Regulation of hepatocyte bile salt cotransporters during hepatic regeneration. Am. J. Physiol. 1997; 273: G621-7.
7. 7 Kullack-Ublick GA, Beuers U, Paumgartner G. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology 1996; 23: 1053-60.
8. +/taurocholate transporter (ntcp) promoter activity via rat GH and prolactin (PRL) receptors by inducing Sat5. Hepatology 1997; 26: 262A (Abstract).
9. 9 Ganguly TC, O'Brien ML, Karpen SJ, Hyde JF, Suchy FJ, Vore M. Regulation of the rat liver sodium-dependent bile acid transporter gene by prolactin. Modulation of transcriptional activation by Sat5. J. Clin. Invest. 1997; 99: 2906-14.
10. 10 Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996; 111: 193-8.
11. 11 Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J. Clin. Invest. 1998; 101: 2092-100.
12. +/bile acid cotransporter. J. Clin. Invest. 1994; 93: 1326-31.
13. 13 Wong MH, Oelkers P, Dawson PA. Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J. Biol. Chem. 1995; 270: 27228-34.
14. 14 Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ. Functional expression, cloning and characterization of the hepatocyte Na/bile acid cotransport system. Proc. Natl Acad. Sci. USA 1991; 88: 10629-33.
15. 15 Kullak-Ublick GA, Hagenbuch B, Stieger B et al. Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 1994; 20: 411-16.
16. 16 Kullak-Ublick GA, Hagenbuch B, Stieger B et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995; 109: 1274-82.
17. 17 Torres AM, Lunazzi GC, Stremmel W, Tiribelli C. Bilitranslocase and sulfobromophthalein/bilirubin-binding protein are both involved in the hepatic uptake of organic unions. Proc. Natl Acad. Sci. USA 1993, 90: 8136-9.
18. 18 Wolkoff AW. Hepatocellular sinusoidal membrane organic anion transport and transporters. Semin. Liver Dis. 1996; 16: 121-7.
19. 19 Bossuyt X, Mueller M, Hagenbuch B, Meier PJ. Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J. Pharmacol. Exp. Ther. 1996; 276: 891-6.
20. 20 Kontaxi M, Echkardt U, Hagenbuch B, Stieger B, Meier PJ, Petzinger E. Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. J. Pharmacol. Exp. Ther. 1996; 279: 1507-13.
21. +-independent organic anion transporter. Proc. Natl Acad. Sci. USA 1994; 91: 133-7.
22. 22 Masuda S, Saito H, Nonoguchi H, Tomita K, Inui K. mRNA distribution and membrane localisation of the OAT-K1 organic anion transporter in rat renal tubules. FEBS Lett. 1997; 407: 127-31.
23. 23 Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science 1995; 268: 866-9.
24. 24 Lu R, Kanai N, Bao Y, Schuster VL. Cloning, in vitro expression and tissue distribution of human prostaglandin transporter cDNA (hPGT). J. Clin. Invest. 1996; 98: 1142-9.
25. 25 Noe B, Hagenbuch B, Stieger B, Meier PJ. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc. Natl Acad. Sci. USA 1997; 94: 10 346-50.
26. 26 Kanai N, Lu R, Bao Y, Wolkoff AW, Schuster VL. Transient expression of oatp organic anion transporter in mammalian cells: Identification of candidate substrate. Am. J. Physiol. 1996; 270: F319-25.
27. 27 Noe B, Pascolo L, Ostrow JD, Tiribelli C, Meier PJ. Oatp family proteins expressed in oocytes are not involved in the uptake of unconjugated bilirubin (Abstract). Hepatology 1997; 26: 572A.
28. 28 Braakman I, Groothius GMM, Meijer DKF. Zonal compartmentation of perfused rat liver: Plasma reappearance of rhodamine B explained. J. Pharmacol. Exp. Ther. 1989; 249: 869-73.
29. 29 Braakman I, Verest O, Pijning T, Meijer DKF, Groothuis GM. Zonal distribution of the cation lucigenin in rat liver: Influence of taurocholate. Mol. Pharmacol. 1990; 36: 532-6.
30. 30 Gruendemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-52.
31. 31 Okuda M, Saito H, Urakami Y, Takano M, Inui K. cDNA cloning and functional expression of a novel rat kidney organic cation transporter. Biochim. Biophys. Res. Commun. 1996; 224: 500-7.
32. 32 Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. Cloning and functional expression of a human liver organic cation transporter. Mol. Pharmacol. 1997; 51: 913-21.
33. 33 Jansen PLM, Peters WH, Lamers WHL. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transporter. Hepatology 1985; 5: 573-9.
34. 34 Takikawa H, Sano N, Narita T et al. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 1991; 14: 352-60.
35. 35 Kobayashi K, Sogame Y, Hayashi K, Nicotera P, Orrenius S. ATP stimulates the uptake of S-dinitrophenyl glutathione by rat liver plasma membrane vesicles. FEBS Lett. 1988; 240: 55-8.
36. 36 Ishikawa T, Mueller M, Klunemann C, Schaub T, Keppler D. ATP-depcndent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J. Biol. Chem. 1990; 265: 19 279-86.
37. 37 Nishida T, Gatmaitan Z, Roy-Chowdhury J, Arias IM. Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. J. Clin. Invest. 1992; 90: 2130-5.
38. 38 Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 1994; 269: 27 807-10.
39. 39 Müller M, Meijer C, Zaman GJ et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl Acad. Sci. USA 1994; 91: 13 033-7.
40. 40 Paulusma CC, Bosma PJ, Zaman GJ et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126-8.
41. 41 Taniguchi K, Wada M, Kohno K at al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996; 56: 4126-9.
42. 42 Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. Prog. Liver Dis. 1996, 14: 55-67.
43. 43 Chu XY, Kato Y, Sugiyama Y. Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. Cancer Res. 1997; 57: 1934-8.
44. 44 Kool M, de Haas M, Scheffer GL et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5 homologues of multidrug resistance-associated protein gene (MRP1) in human cancer cells. Cancer Res. 1997; 57: 3537-47.
45. 45 Madon J, Hagenbuch B, Gerloff T, Landmann L, Meier PJ, Stiegen B. Identification of a novel multidrug resistance-associated protein (mrp6) at the lateral plasma membrane of rat hepatocytes. Hepatology 1998; 28: 400A (Abstract).
46. 46 Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of canalicular isoform of MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996; 23: 1061-6.
47. 47 Adachi Y, Kobayashi H, Kurumi Y, Shouji M, Kitano M, Yamamoto T. Bilirubin diglucuronide transport by rat liver canalicular membrane vesicles: Stimulation by bicarbonate ion. Hepatology 1991, 14: 1251-8.
48. 48 Adachi Y, Kamisako T, Okuyama Y, Miya H. Intrahepatic cholestasis. Jpn. J. Clin. Med. 1996; 54: 788-93 (in Japanese with English abstract).
49. 49 Trauner M, Arrese M, Soroka CJ et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113: 255-64.
50. 50 Paulusma CC, Kool M, Bosma PJ et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin Johnson syndrome. Hepatalogy 1997; 25: 1539-42.
51. 51 Wada M, Toh S, Taniguchi K et al. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum. Mol. Genet. 1998; 7: 203-97.
52. 52 Inoue M, Kinne R, Tran T, Arias IM. Taurocholate transport by rat canalicular membrane vesicles. Evidence for the presence of an Na-independent transport system. J. Clin. Invest. 1984; 73: 659-63.
53. 53 Kast C, Stieger B, Winterhalter KH, Meier PJ. Hepatocellular transport of bile acids. Evidence for distinct sub-cellular localization of electrogenic and ATP-dependent taurocholate transport in rat hepatocytes. J. Biol. Chem. 1994; 269: 5179-86.
54. 54 Adachi Y, Koboyashi H, Kurumi Y, Shouji M, Kitano M, Yamamoto T. ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 1991; 14: 655-9.
55. 55 Arias IM. The bilology of the bile canaliculus, 1993. Hepatology 1993; 17: 318-29.
56. 56 Nishida T, Hardenbrook C, Gatmaitan Z, Arias IM. ATP-dependent organic anion transporting system in normal and TR-rat liver canalicular membranes. Am. J. Physiol. 1992; 262: G629-35.
57. 57 Bossard R, Stieger B, O'Neill B, Fricker G, Meier PJ. Ethinylestradiol treatment induces multiple canalicular transport alterations in rat liver. J. Clin. Invest. 1993; 91: 2714-20.
58. 58 Adachi Y, Miya H, Okuyama Y, Kamisako T, Yamamoto T. Hepatocyte canalicular transport of organic anions in bile duct-ligated rats. Int. Hepatol. Commun. 1996; 5: 326-30.
59. 59 Mueller M, Ishikawa T, Berger U et al. ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110 kDa glycoprotein binding ATP and bile salt. J. Biol. Chem. 1991; 266: 18 920-6.
60. 60 Sippel CJ, Suchy FJ, Ananthanarayanan M, Perlmutter DH. The rat liver ecto-ATPase is also a canalicular bile acid transport protein. J. Biol. Chem. 1993; 268: 2083-91.
61. 61 Ortiz DF, St Pierre MV, Abdulmessih A, Arias IM. A yeast ATP-binding cassette-type protein mediating ATP-dependent bile acid transport. J. Biol. Chem. 1997; 272: 15 358-65.
62. 62 Childs S, Yeh R, Georges E, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res. 1995; 55: 2029-34.
63. 63 Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J. Biol. Chem. 1998; 273: 10 046-50.
64. 64 Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA 1987; 84: 7735-8.
65. 65 Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem. 1989; 264: 11 693-8.
66. 66 Mueller M, Jansen PL. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 1997; 272: G1285-303.
67. 67 Buschman E, Gros P. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res. 1994; 54: 4892-8.
68. 68 Schinkel AH, Roelofs EM, Borst P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 1991; 51: 2628-35.
69. 69 Buschman E, Arceci RJ, Croop JM et al. Mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J. Biol. Chem. 1992; 267: 18 093-9.
70. 70 Smit JJM, Schinkel AH, Mol CA et al. Tissue distribution of the human MDR3 P-glycoprotein. Lab Invest 1994; 71: 638-49.
71. 71 Smit JJM, Schinkel AH, Oude Elierink RP et al. Homozygous disruption of murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
72. 72 Deleuze JF, Jacquemin E, Dubuisson C et al. Defect of multidrug resistance 3 gene expression in subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-8.
73. 73 De Vree JML, Jacquemin E, Sturm E et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl Acad. Sci. USA 1998; 95: 282-7.
74. 74 Mueller M, Hooiveld GJEJ, Vos TA et al. Strong induction of MDR2 P-glycoprotein expression in livers of simvastatin-treated rats. Hepatology 1997; 26: 379A (Abstract).
75. 75 Kamisako T, Adachi Y. Marked improvement of cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. Am. J. Gastroenterol. 1995; 90: 1187-8.